YSB's (HKG:9885) executive director, Fei Chen, acquired an additional 100,000 shares in the company from the open market on Wednesday, a same-day Hong Kong bourse filing said.
Shares of the pharmaceutical retailer were down over 1% in Thursday afternoon trading.
Since April, Chen has increased his shareholding by 1.3 million shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.